Can observational studies provide a realistic alternative to randomized controlled trials in palliative care

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 23, Issue 2, 2009, Pages 106-113

  Hadley, Gina ^a,b   Derry, Sheena ^c   Moore, R Andrew ^c   Wee, Bee ^d  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Observational study; Palliative care; Quality; Randomized controlled trial; Size; Validity

Indexed keywords

CORTICOSTEROID; LAXATIVE; OPIATE; RADIOISOTOPE; SEDATIVE AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; ARTICLE; CANCER PAIN; CANCER PATIENT; CHRONIC LUNG DISEASE; DELIRIUM; DEMENTIA; E-MAIL; EVIDENCE BASED MEDICINE; GOLD STANDARD; HEART DISEASE; HUMAN; LUNG CANCER; MEDICAL EXPERT; MEDLINE; OBSERVATIONAL STUDY; PALLIATIVE THERAPY; PROSPECTIVE STUDY; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SAMPLE SIZE; SEDATION; SPIRITUAL CARE; SURVIVAL; SYMPTOM; TERMINAL DISEASE; TERMINALLY ILL PATIENT; VALIDITY; WORLD HEALTH ORGANIZATION; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; METHODOLOGY;

COHORT STUDIES; CROSS-SECTIONAL STUDIES; EVIDENCE-BASED MEDICINE; HUMANS; PALLIATIVE CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; RETROSPECTIVE STUDIES;

EID: 68549091011     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.1080/15360280902899921     Document Type: Article

References (48)

1. Rinck GC, van den Bos GA, Kleijnen J, et al. Methodologic issues in effectiveness research on palliative cancer care: a systematic review. J Clin Oncol. 1997;15:1697-1707.
2. Grande GE, Todd CJ. Why are trials in palliative care so difficult? Palliat Med. 2000;14:69-74.
3. Mazzocato C, Sweeney C, Bruera E. Clinical research in palliative care: choice of trial design. Palliat Med. 2001;15:261-264
4. Mularski RA, Rosenfeld K, Joel Coons S, et al. Measuring outcomes in randomized prospective trials in palliative care. J Pain Symptom Manage. 2007;34:S7-S19.
5. Wee B, Hadley G, Derry S. How useful are systematic reviews in palliative care? Survey of 25 Cochrane systematic reviews. BMC Palliat Care. 2008;7:13.
6. Benson K, Hartz AJ. A comparison of observational studies and randomised controlled trials. New Engl J Med. 2000;342:1878-1886.
7. Moore RA, McQuay HJ. Observational studies. In: Moore A, McQuay HJ, eds. Bandolier's Little Book of Making Sense of the Medical Evidence. Oxford: Oxford University Press; 2006.
8. Higginson IJ. Evidence based palliative care. There is some evidence-and there needs to be more. BMJ. 1999;319:462-463.
9. Regnard C, Hockley J. A Guide to Symptom Relief in Palliative Care, 5th ed. Oxford: Radcliffe Medical Press; 2004.
10. Ruppen W, Derry S, McQuay H, Moore RA. Incidence of epidural hematoma, infection, and neurologic injury in obstetric patients with epidural analgesia/ anesthesia. Anesthesiology. 2006;105:394-399.
11. Lemeshow AR, Blum RE, Berlin JA, Stoto MA, Colditz GA. Searching one or two databases was insufficient for meta-analysis of observational studies. J Clin Epidemiol. 2005;58:867-873.
12. Christakis NA, Escarce JJ. Survival of Medicare patients after enrollment in hospice programs. N Engl J Med. 1996;335:172-178.
13. Eve A, Higginson IJ. Minimum dataset activity for hospice and hospital palliative care services in the UK 1997/98. Palliat Med. 2000;14:395-404.
14. Ferńandez Gonźalez MJ, Roces Camino JR, Vald́es Ǵomez C, Vallina Blanco P. Equipo de soporte de atencíon domiciliaria. Resumen de la actividad realizada en los dieciśeis primerosmeses de funcionamiento del ESAD. Á rea Sanitaria V-Gijón (1 de octubre, 2000 a 31 de enero, 2002). [Analysis of the activity of a Home Care Support Team.] Sociedad Espãnola de Cuidados Paliativos. 2003;10:72-7. Also available at http://www.secpal.com/medicina paliativa/index.php? acc=verart&idart=140 (accessed January 6, 2009).
15. Higginson IJ, Wilkinson S. Marie Curie nurses: enabling patients with cancer to die at home. Br J Community Nurs. 2002;7:240-344.
16. Potter J, Hami F, Bryan T, Quigley C. Symptoms in 400 patients referred to palliative care services: prevalence and patterns. Palliat Med. 2003;17:310-314.
17. Dafermou A, Colamussi P, Giganti M, Cittanti C, Bestagno M, Piffanelli. A multicentre observational study of radionuclide therapy in patients with painful bone metastases of prostate cancer. Eur J Nucl Med. 2001;28:788-798.
18. Crawford J, Demetri GD, Gabrilove JL,BlasiMV, Sarokhan BJ, Glaspy J. Clinical benefits of epoetin alfa therapy in patients with lung cancer. Clin Lung Cancer. 2002;3:180-190. (Pubitemid 34213648)
19. Higginson IJ, Hearn J, Myers K, Naysmith A. Palliative day care: what do services do? Palliative Day Care Project Group. Palliat Med. 2000;14:277-286.
20. Anderson H, Ward C, Eardley A, et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med. 2001;15:279-286.
21. Baýes R, Limonero JT, Barreto P, Comas MD. Protocolo de una investigacíon multićentrica sobre aspectos emocionales en enfermos en situacíon terminal. [A research system for emotional needs of terminal patients.] Sociedad Espãnola de Cuidados Paliativos. 2001;8:71-79. Also available at http://www.secpal.com/ medicina paliativa/index.php?acc=verart&idart=39 (accessed January 6, 2008).
22. Logie DE, Harding R. An evaluation of a morphine public health programme for cancer and AIDS pain relief in Sub-Saharan Africa. BMC Public Health. 2005;5:82.
23. London MR, McSkimming S, Drew N, Quinn C, Carney B. Evaluation of a comprehensive, Adaptable, Life-Affirming, Longitudinal (CALL) palliative care project. J Palliat Med. 2005;8:1214-1225.
24. Addington-Hall JM, Karlsen S. A national survey of health professionals and volunteers working in voluntary hospice services in the UK. I. Attitudes to current issues affecting hospices and palliative care. Palliat Med. 2005;19:40-48.
25. Addington-Hall JM, Karlsen S. A national survey of health professionals and volunteers working in voluntary hospices in the UK. II. Staff and volunteers' experiences of working in hospices. Palliat Med. 2005;19:49-57. (Pubitemid 40202058)
26. Higginson IJ, Astin P, Dolan S. Where do cancer patients die? Ten-year trends in the place of death of cancer patients in England. Palliat Med. 1998;12:353-363.
27. Higginson IJ, Jarman B, Astin P, Dolan S. Do social factors affect where patients die: an analysis of 10 years of cancer deaths in England. J Public Health Med. 1999;21:22-28.
28. Iwashyna TJ, Zhang JX, Christakis NA. Diseasespecific patterns of hospice and related healthcare use in an incidence cohort of seriously ill elderly patients. J Palliat Med. 2002;5:531-538.
29. Iwashyna TJ, Chang VW, Zhang JX, Christakis NA. The lack of effect of market structure on hospice use. Health Serv Res. 2002;37:1531-1551.
30. Lamont EB, ChristakisNA. Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med. 2001;134:1096-1105.
31. Lamont EB, Christakis NA. Physician factors in the timing of cancer patient referral to hospice palliative care. Cancer. 2002;94:2733-2737.
32. Balboni TA, Vanderwerker LC, Block SD, et al. Religiousness and spiritual support among advanced cancer patients and associations with end-of-life treatment preferences and quality of life. J Clin Oncol. 2007;25:555-560.
33. Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage. 2001;21:467-472.
34. Hanks GW, Trueman T, Twycross RG. Corticosteroids in terminal cancer-a prospective analysis of current practice. Postgrad Med J. 1983;59: 702-706.
35. Higginson IJ, Hearn J. A multicenter evaluation of cancer pain control by palliative care teams. J Pain Symptom Manage. 1997;14:29-35.
36. Meuser T, Pietruck C, Radbruch L, Stute P, Lehmann KA, Grond S. Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology. Pain. 2001;93:247-257.
37. Miccinesi G, Paci E, Toscani F, et al. [Quality of life at the end of life. Analysis of the quality of life of oncologic patients treated with palliative care. Results of a multicenter observational study (staging).] Epidemiol Prev. 1999;23:333-345.
38. Monti M, Castellani L, Berlusconi A, Cunietti E. Use of red blood cell transfusions in terminally ill cancer patients admitted to a palliative care unit. J Pain Symptom Manage. 1996;12:18-22.
39. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage. 2001;21:282-289.
40. Sykes NP. The relationship between opioid use and laxative use in terminally ill cancer patients. Palliat Med. 1998;12:375-382.
41. Tuca Rodríguez A, Nabal Vicũna M, Porta Sales J, Ylla-Cataĺa Boŕe E. Estudio multićentrico catalanobalear sobre la sedacíon terminal enCuidados Paliativos. [Multi-center catalano-balear study about the terminal sedation in Palliative Care.] Sociedad Espãnola de Cuidados Paliativos 1999, 6:153-158. Also available at http://www.secpal.com/medicina paliativa/index.php? acc=verart&idart=185 (accessed January 6, 2008).
42. Apolone G, Mangano S, Compagnoni A, et al. Cancer Pain Outcome Research Study Group (CPOR SG): a multidisciplinary project to improve the quality of cancer pain management in Italy: background, methods, and preliminary results. J Ambul Care Manage. 2006;29:332-341.
43. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. New Engl J Med. 2000;342:1887-1892.
44. Geborek P, Crnkic M, Petersson IF, Saxne T. South Swedish Arthritis Treatment Group: Etanercept, infliximab, and leflunomide in established rheumatoid arthritis: clinical experience using a structured follow up programme in southern Sweden. Ann Rheum Dis. 2002;61:793-798.
45. Jobanputra P, Barton P, Bryan S, Burls A. The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2002;6:1-110.
46. Flather MD, Farkouh ME, Pogue JM, Yusuf S. Strengths and limitations of meta-analysis: larger studies may bemore reliable. Control Clin Trials. 1997;18:568-579.
47. Moore RA, Gavaghan D, Tram̀er MR, Collins SL, McQuay HJ. Size is everything-large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. Pain. 1998;78:209-216
48. Shuster JJ. Fixing the number of events in large comparative trials with low event rates: a binomial approach. Control Clin Trials. 1993;14:198-208.